No Data
No Data
12 Health Care Stocks Moving In Wednesday's Intraday Session
Genprex Gets Dosage Escalation Approval in Small-Cell Lung Cancer Treatment Trial; Shares Jump
Express News | Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination With Tecentriq® in Extensive Stage Small Cell Lung Cancer
Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa Gene Therapy in Combination With Tecentriq in Extensive Stage Small Cell Lung Cancer
Express News | Genprex Inc -Received Letter From Nasdaq on Failure to Satisfy a Continued Listing Rule or Standard
Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes
No Data
No Data
104799539 : What can be purchased while on the watchlist?